
Elements of Launch Intensive
Worthy Marketing Group
New York, USA (Remote)
Emeryville, CA (Hybrid)
Posted 2 weeks ago
The other 99% submit and hope. You're about to do something different.
Kyverna is a clinical-stage biopharmaceutical company focused on liberating autoimmune patients through the curative potential of cell therapy. Kyverna’s lead autologous CD19-targeting CAR T-cell therapy candidate, miv-cel (mivocabtagene autoleucel, KYV-101), has demonstrated the potential to fundamentally change the treatment paradigm across multiple B-cell-driven autoimmune diseases.Kyverna is advancing its potentially first-in-class neuroimmunology franchise with its recently completed registrational trial in stiff person syndrome and an ongoing registrational trial for generalized myasthenia gravis. The Company is also harnessing other KYSA trials and investigator-initiated trials, including in multiple sclerosis and rheumatoid arthritis, to inform the next priority indications. Additionally, its next generation pipeline includes CAR T-cell therapies deploying novel innovations to improve patient access and experience.

Worthy Marketing Group
New York, USA (Remote)

Galvanick
USA (Remote)

Venture Media
California, MO (Remote)

Limitless Advisor Coaching
Park City, UT (Remote)

Carrollton Injury Law
Carrollton, TX (On-site)
12+ roles like Sr. Director, Marketing Promotions at Kyverna Therapeutics
See more similar roles and save the ones you want to track.